Cocrystal Pharmaincis A Clinical Stage Biotechnology Company Based In Bothellwashingtonthe Company Focuses On Discovering And Developing Novel Antiviral Therapeutics To Combat Serious Viral Diseasesutilizing Structure Based Drug Discovery Technologiescocrystal Aims To Create Firstand Best In Class Antiviral Drugs With An Emphasis On Safetybroad Spectrum Efficacyand Resistance Management Cocrystal S Pipeline Includes Candidates For Influenzanorovirusand Coronaviruseswith Programs Designed For Oral Or Inhaled Administrationcurrent Projects Include An Oral Pb2 Inhibitor For Influenza In Phase 2A Trialsan Inhaled Pb2 Inhibitor Preparing For Clinical Testingand A Dual Coronavirus Norovirus Oral Antiviral In Phase 1 Studiesthe Company Also Has A Preclinical Candidate Targeting Norovirus And A Program For Hepatitis C In Developmentcocrystal Is Committed To Addressing The Global Need For Effective Antiviralsparticularly In The Context Of Pandemic Preparedness
